STOK- Stoke Therapeutics, Inc.

Name: Stoke Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Stoke Therapeutics, Inc. (STOK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. STOK is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Skorpios Trust	3.91M	$128.47M	-
CEO	Smith Ian F	380.0K	$12.50M	-
Dir	Krainer Adrian R.	283.3K	$9.32M	-
Other	Tzianabos Arthur	118.7K	$3.90M	-
Dir	Kaye Edward M. Md	110.9K	$3.65M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2026	Krainer Adrian R.	Director	Sell	33,243	$39.74	$1,320,963.79	-10.5%	-	-
Mar 10, 2026	Tzianabos Arthur74	Interim Executive Chair	Sale+OE	4,355	$40.00	$174,214.37	-12.2%	-	-
Dec 8, 2025	Kaye Edward M. Md47	Director	Sell	13,430	$32.27	$433,385.06	-7.8%	+16.0%	-
Dec 8, 2025	Allan Jonathan46	General Counsel &Corp Sec	Sell	3,978	$32.28	$128,411.36	-13.1%	+16.0%	-
Dec 5, 2025	Allan Jonathan46	General Counsel &Corp Sec	Sale+OE	9,803	$31.25	$306,322.15	-8.4%	+12.2%	-
Dec 5, 2025	Kaye Edward M. Md47	Director	Sale+OE	15,001	$31.13	$466,958.91	-4.3%	+12.2%	-
Dec 5, 2025	Ticho Barry52	Chief Medical Officer	Sale+OE	5,358	$31.19	$167,115.04	-5.7%	+12.2%	-
Dec 3, 2025	Ticho Barry52	Chief Medical Officer	Sale+OE	4,020	$30.22	$121,468.37	-5.7%	+9.1%	-
Dec 3, 2025	Kaye Edward M. Md47	Director	Sale+OE	2,136	$30.22	$64,541.43	-1.0%	+9.1%	-
Dec 3, 2025	Allan Jonathan46	General Counsel &Corp Sec	Sale+OE	4,576	$30.22	$138,268.18	-5.1%	+9.1%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC